DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 215 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $53,380,547 | +2.6% | 4,753,388 | +13.4% | 0.01% | 0.0% |
| Q1 2024 | $52,016,751 | +3.4% | 4,191,519 | +16.5% | 0.01% | 0.0% |
| Q4 2023 | $50,288,003 | +15.3% | 3,597,139 | +21.8% | 0.01% | 0.0% |
| Q3 2023 | $43,611,542 | -6.0% | 2,952,711 | -17.8% | 0.01% | -10.0% |
| Q2 2023 | $46,412,090 | +27.9% | 3,592,267 | -2.9% | 0.01% | +25.0% |
| Q1 2023 | $36,279,852 | +114.3% | 3,698,252 | +132.4% | 0.01% | +100.0% |
| Q4 2022 | $16,929,251 | +117824.6% | 1,591,095 | +15.7% | 0.00% | 0.0% |
| Q3 2022 | $14,356 | -34.5% | 1,375,086 | -21.0% | 0.00% | -20.0% |
| Q2 2022 | $21,922 | -99.9% | 1,741,225 | -20.2% | 0.01% | 0.0% |
| Q1 2022 | $23,639,000 | -10.1% | 2,180,728 | +16.7% | 0.01% | 0.0% |
| Q4 2021 | $26,301,000 | +22.1% | 1,869,267 | +66.6% | 0.01% | +25.0% |
| Q3 2021 | $21,549,000 | +18.1% | 1,121,734 | -39.4% | 0.00% | 0.0% |
| Q2 2021 | $18,246,000 | -43.8% | 1,852,477 | -43.9% | 0.00% | -50.0% |
| Q1 2021 | $32,487,000 | +258.8% | 3,304,860 | +62.4% | 0.01% | +300.0% |
| Q4 2020 | $9,055,000 | +162.1% | 2,034,898 | +154.5% | 0.00% | +100.0% |
| Q3 2020 | $3,455,000 | -47.8% | 799,647 | +7.2% | 0.00% | -66.7% |
| Q2 2020 | $6,619,000 | +35.3% | 746,232 | -46.2% | 0.00% | +50.0% |
| Q1 2020 | $4,892,000 | +281.6% | 1,385,973 | +518.1% | 0.00% | – |
| Q4 2019 | $1,282,000 | +102.5% | 224,233 | +26.5% | 0.00% | – |
| Q3 2019 | $633,000 | -41.5% | 177,195 | -34.6% | 0.00% | – |
| Q2 2019 | $1,082,000 | -55.8% | 271,134 | -19.1% | 0.00% | -100.0% |
| Q1 2019 | $2,450,000 | +4.6% | 335,133 | +30.9% | 0.00% | 0.0% |
| Q4 2018 | $2,343,000 | -27.4% | 256,102 | -1.6% | 0.00% | 0.0% |
| Q3 2018 | $3,228,000 | -25.2% | 260,337 | -8.0% | 0.00% | 0.0% |
| Q2 2018 | $4,317,000 | +16.0% | 283,077 | +51.1% | 0.00% | 0.0% |
| Q1 2018 | $3,720,000 | +19.0% | 187,389 | +12.1% | 0.00% | 0.0% |
| Q4 2017 | $3,127,000 | -80.9% | 167,234 | -78.0% | 0.00% | -75.0% |
| Q3 2017 | $16,369,000 | +3715.6% | 761,346 | +1612.9% | 0.00% | – |
| Q2 2017 | $429,000 | +29.2% | 44,449 | -20.4% | 0.00% | – |
| Q1 2017 | $332,000 | -81.3% | 55,864 | -87.6% | 0.00% | – |
| Q4 2016 | $1,780,000 | -81.8% | 450,491 | -51.8% | 0.00% | -100.0% |
| Q3 2016 | $9,796,000 | +36.7% | 933,756 | +90.0% | 0.00% | +50.0% |
| Q2 2016 | $7,165,000 | -13.5% | 491,402 | +14.1% | 0.00% | -33.3% |
| Q1 2016 | $8,286,000 | -30.6% | 430,666 | -12.8% | 0.00% | -25.0% |
| Q4 2015 | $11,935,000 | +15.1% | 493,982 | +16.9% | 0.00% | +33.3% |
| Q3 2015 | $10,368,000 | +563.3% | 422,503 | +533.4% | 0.00% | – |
| Q2 2015 | $1,563,000 | +106.5% | 66,703 | +97.6% | 0.00% | – |
| Q1 2015 | $757,000 | – | 33,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
| Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
| Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
| Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
| Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
| RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
| Maven Securities LTD | 264,989 | $931,000 | 0.29% |
| Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
| GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |